- Home
- CRVS vs LOCO Comparison
CRVS vs LOCO Comparison
Compare CRVS & LOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- LOCO
- Stock Information
- Founded
- CRVS 2014
- LOCO 1980
- Country
- CRVS United States
- LOCO United States
- Employees
- CRVS N/A
- LOCO N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- LOCO Restaurants
- Sector
- CRVS Health Care
- LOCO Consumer Discretionary
- Exchange
- CRVS Nasdaq
- LOCO Nasdaq
- Market Cap
- CRVS 305.4M
- LOCO 323.7M
- IPO Year
- CRVS 2016
- LOCO 2014
- Fundamental
- Price
- CRVS $5.55
- LOCO $10.68
- Analyst Decision
- CRVS Strong Buy
- LOCO Buy
- Analyst Count
- CRVS 4
- LOCO 2
- Target Price
- CRVS $15.00
- LOCO $18.00
- AVG Volume (30 Days)
- CRVS 461.1K
- LOCO 206.6K
- Earning Date
- CRVS 08-07-2025
- LOCO 07-31-2025
- Dividend Yield
- CRVS N/A
- LOCO N/A
- EPS Growth
- CRVS N/A
- LOCO N/A
- EPS
- CRVS N/A
- LOCO 0.85
- Revenue
- CRVS N/A
- LOCO $479,690,000.00
- Revenue This Year
- CRVS N/A
- LOCO $6.29
- Revenue Next Year
- CRVS N/A
- LOCO $1.56
- P/E Ratio
- CRVS N/A
- LOCO $12.12
- Revenue Growth
- CRVS N/A
- LOCO 1.85
- 52 Week Low
- CRVS $2.54
- LOCO $8.29
- 52 Week High
- CRVS $10.00
- LOCO $14.25
- Technical
- Relative Strength Index (RSI)
- CRVS 69.70
- LOCO 54.40
- Support Level
- CRVS $5.03
- LOCO $10.14
- Resistance Level
- CRVS $5.81
- LOCO $10.69
- Average True Range (ATR)
- CRVS 0.32
- LOCO 0.25
- MACD
- CRVS 0.09
- LOCO 0.02
- Stochastic Oscillator
- CRVS 85.22
- LOCO 90.19
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About LOCO El Pollo Loco Holdings Inc.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.